Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
1997-10-28
|
pubmed:abstractText |
Exposure to ozone causes symptoms, changes in lung function, and airway inflammation. We studied whether individuals who differ in lung-function responsiveness to ozone, or in smoking status, also differ in susceptibility to airway inflammation. Healthy subjects were selected on the basis of responsiveness to a classifying exposure to 0.22 ppm ozone for 4 h with exercise (responders, with a decrease in FEV1 > 15%; and non-responders, with a decrease in FEV1 < 5%). Three groups were studied: nonsmoker-nonresponders (n = 12), nonsmoker-responders (n = 13), and smokers (n = 13, 11 nonresponders and two responders). Each subject underwent two exposures to ozone and one to air, separated by at least 3 wk; bronchoalveolar and nasal lavages were performed on three occasions: immediately (early) and 18 h (late) after ozone exposure, and either early or late after air exposure. Recovery of polymorphonuclear leukocytes (PMN) increased progressively in all groups, and by up to 6-fold late after ozone exposure. Interleukin-6 (IL-6) and IL-8 increased early (by up to 10-fold and up to 2-fold, respectively), and correlated with the late increase in PMN. Lymphocytes, mast cells, and eosinophils also increased late after exposure. We conclude that ozone-induced airway inflammation is independent of smoking status or airway responsiveness to ozone.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
728-36
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9309986-Adolescent,
pubmed-meshheading:9309986-Adult,
pubmed-meshheading:9309986-Bronchial Hyperreactivity,
pubmed-meshheading:9309986-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:9309986-Disease Susceptibility,
pubmed-meshheading:9309986-Female,
pubmed-meshheading:9309986-Forced Expiratory Volume,
pubmed-meshheading:9309986-Humans,
pubmed-meshheading:9309986-Inflammation,
pubmed-meshheading:9309986-Interleukin-6,
pubmed-meshheading:9309986-Interleukin-8,
pubmed-meshheading:9309986-Male,
pubmed-meshheading:9309986-Neutrophils,
pubmed-meshheading:9309986-Oxidants, Photochemical,
pubmed-meshheading:9309986-Ozone,
pubmed-meshheading:9309986-Smoking
|
pubmed:year |
1997
|
pubmed:articleTitle |
Airway inflammation in smokers and nonsmokers with varying responsiveness to ozone.
|
pubmed:affiliation |
Department of Medicine, University of Rochester School of Medicine, New York 14642-8692, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|